Cart
sales@molnova.com
Pseudolaric acid A
CAS No. 82508-32-5
Pseudolaric acid A( —— )
Catalog No. M19146 CAS No. 82508-32-5
Pseudolaric acid A and -B can inhibit the growth of particular cell type.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 126 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePseudolaric acid A
-
NoteResearch use only, not for human use.
-
Brief DescriptionPseudolaric acid A and -B can inhibit the growth of particular cell type.
-
DescriptionPseudolaric acid A and -B can inhibit the growth of particular cell type.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82508-32-5
-
Formula Weight388.46
-
Molecular FormulaC22H28O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (257.43 mM)
-
SMILESCC1=CCC23CCC(C2(CC1)OC(=O)C)C(OC3=O)(C)C=CC=C(C)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BAY 11-7082
BAY 11-7082 a NF-κB inhibitor that selectively and irreversibly inhibits the TNF-α-inducible phosphorylation of IκBα (IC50=10 uM).
-
(R)-(-)-Ibuprofen
An enantiomer of Ibuprofen that is generally not considered a COX inhibitor and is instead thought to be involved in pathways of lipid metabolism as it is incorporated into triglycerides along with fatty acids.
-
Didox
A ribonucleotide reductase inhibitor; overcomes Bcl-2 mediated radiation resistance in PC-3 cells.
